Observational prospective study describing the global patient care and follow-up of prostate cancer patients treated with Degarelix (DUO study (Dialogue in Uro-Oncology)) First published 20/06/2017 Last updated 02/04/2024 EU PAS number:EUPAS18906 Study Finalised